The elimination of CD4+ FOXP3+ Treg cells by T cells expressing the chimeric Klrk1/NKG2D receptor in the ovarian tumor microenvironment inhibited tumor growth and increased survival in mice27. Here, KLRK1 is linked to neoplasm.